SecSonar.com

PMGC Holdings Inc. (ELAB)

PMGC Holdings Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

PMGC Holdings Inc. (ELAB) is a Biotechnology company based in US with a market capitalization of $3.4M. Revenue declined 76.1% year-over-year and free cash flow was negative at -$6.4M. This page tracks ELAB's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 2 employees · IPO Nov 21, 2023

Valuation

Valuation & price

$2.08 · as of May 17, 2026 · -99.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.43

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$867$434$1.14Jul 25Dec 25Jul 26Jul 7, 25$756.48Jul 9, 25$769.92Jul 11, 25$743.04Jul 15, 25$769.92Jul 17, 25$769.92Jul 21, 25$803.52Jul 23, 25$776.64Jul 25, 25$766.08Jul 29, 25$745.92Jul 31, 25$702.72Aug 4, 25$678.72Aug 6, 25$642.24Aug 11, 25$648.96Aug 13, 25$662.40Aug 15, 25$648.96Aug 19, 25$665.28Aug 21, 25$635.52Aug 25, 25$705.60Aug 27, 25$669.12Aug 29, 25$544.32Sep 3, 25$464.64Sep 5, 25$434.88Sep 9, 25$422.40Sep 11, 25$458.88Sep 16, 25$547.20Sep 18, 25$585.60Sep 22, 25$540.48Sep 24, 25$511.68Sep 26, 25$518.40Sep 30, 25$507.84Oct 2, 25$522.24Oct 6, 25$519.36Oct 8, 25$603.84Oct 10, 25$525.12Oct 14, 25$866.88Oct 16, 25$746.88Oct 21, 25$645.12Oct 23, 25$586.56Oct 27, 25$571.20Oct 29, 25$560.64Oct 31, 25$569.28Nov 4, 25$552.00Nov 6, 25$520.32Nov 10, 25$537.60Nov 12, 25$543.36Nov 14, 25$508.80Nov 18, 25$469.44Nov 20, 25$457.92Nov 25, 25$503.04Nov 28, 25$509.76Dec 2, 25$516.48Dec 4, 25$478.08Dec 8, 25$474.24Dec 10, 25$414.72Dec 12, 25$369.60Dec 16, 25$315.36Dec 18, 25$209.28Dec 22, 25$192.96Dec 24, 25$153.60Dec 29, 25$134.40Jan 2, 26$136.32Jan 6, 26$134.88Jan 8, 26$33.42Jan 12, 26$31.62Jan 14, 26$21.36Jan 16, 26$19.08Jan 21, 26$20.28Jan 23, 26$21.06Jan 27, 26$20.52Jan 29, 26$19.98Feb 2, 26$20.10Feb 4, 26$12.06Feb 9, 26$10.08Feb 11, 26$10.20Feb 13, 26$8.22Feb 18, 26$7.38Feb 20, 26$7.74Feb 24, 26$7.38Feb 26, 26$7.56Mar 2, 26$6.84Mar 4, 26$6.30Mar 6, 26$4.44Mar 10, 26$4.45Mar 12, 26$4.40Mar 17, 26$4.44Mar 19, 26$3.79Mar 23, 26$3.73Mar 25, 26$1.82Mar 27, 26$1.67Mar 31, 26$5.99Apr 2, 26$5.72Apr 7, 26$3.45Apr 9, 26$5.26Apr 13, 26$5.08Apr 15, 26$4.20Apr 17, 26$3.28Apr 22, 26$3.11Apr 24, 26$2.49Apr 28, 26$2.54Apr 30, 26$2.46May 4, 26$2.33May 6, 26$2.13May 8, 26$1.98May 12, 26$1.89May 14, 26$2.06May 18, 26$1.88May 20, 26$1.74May 22, 26$1.78May 28, 26$1.92Jun 1, 26$1.77Jun 3, 26$1.81Jun 5, 26$1.54Jun 9, 26$1.41Jun 11, 26$1.56Jun 15, 26$1.46Jun 17, 26$1.43Jun 22, 26$1.35Jun 24, 26$1.25Jun 26, 26$1.14Jul 2, 26$1.18
$1.1452-week range$866.88
Loading valuation history…

Fundamentals

Key fundamentals

$3.4M

Market cap

-76.1%

Revenue growth (YoY)

12.7%

Gross margin

-$6.4M

Free cash flow (USD)

-$2.8M

Net debt

Net cash position

2049.1%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2020 → 2025

FY 2020$0.00FY 2021$827.00FY 2022$766.3KFY 2023$1.7MFY 2024$2.5MFY 2025$590.1K
$0$590.1K

Free cash flow by year

2020 → 2025

FY 2020$-217.2KFY 2021$-693.4KFY 2022$-1.6MFY 2023$-4.6MFY 2024$-5.5MFY 2025$-6.4M
-$217.2K-$6.4M

Gross margin by year

2021 → 2025

FY 2021-244.0%FY 202258.4%FY 202366.3%FY 202472.8%FY 202512.7%
-244.0%12.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $-11.21)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventPhase III Results AnnouncedJul 1, 2026Filing
  • 8-K eventBylaw Amendment ApprovedJun 8, 2026Filing
  • 8-K eventResearch Agreement SignedJun 5, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing
  • 8-K eventAudited Financial StatementsMay 13, 2026Filing
  • 8-K eventPatent Application FiledApr 28, 2026Filing
  • 8-K eventTechnology AcquisitionApr 23, 2026Filing
  • 8-K eventLong-Term Agreement SignedApr 21, 2026Filing
  • 8-K eventSecurities Purchase AgreementApr 17, 2026Filing
  • 8-K eventLong-Term Supply AgreementApr 9, 2026Filing

Questions

Frequently asked questions

What is PMGC Holdings Inc.'s market cap?

PMGC Holdings Inc. (ELAB) has a market capitalization of $3.4M.

What is ELAB's P/E ratio?

A meaningful P/E ratio is not available for ELAB — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ELAB's price-to-book (P/B) ratio?

ELAB trades at 0.43 times book value per share.

When did PMGC Holdings Inc. last report earnings?

ELAB last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying ELAB stock?

SEC Form 4 filings show no open-market insider buys at PMGC Holdings Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

ERNA

Ernexa Therapeutics Inc.

$3.4M

VIVS

VivoSim Labs, Inc.

$3.4M

SILO

Silo Pharma, Inc.

$3.6M

CDIO

Cardio Diagnostics Holdings, Inc.

$3.7M

INM

InMed Pharmaceuticals Inc.

$2.9M

ENSC

Ensysce Biosciences, Inc.

$2.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.